EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

This adverse event was reported 744 times

These drugs are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED:

# Drug Count
0 NIRAPARIB 127
1 PEMBROLIZUMAB 77
2 DEXAMETHASONE 68
3 DEXAMETHASONE 1.5 MG 68
4 BEVACIZUMAB 64
5 CARBOPLATIN 51
6 RIBOCICLIB 50
7 LEVETIRACETAM 41
8 PACLITAXEL 41
9 TEMOZOLOMIDE 33
See all common drugs associated with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMCINONIDE 1 0.0123
1 NIRAPARIB 127 0.0086
2 ENASIDENIB MESYLATE 15 0.0072
3 SILTUXIMAB 2 0.0068
4 RIBOCICLIB 50 0.0038
5 ADO-TRASTUZUMAB EMTANSINE 16 0.0032
6 ENFORTUMAB VEDOTIN 3 0.0027
7 BRIGATINIB 5 0.0026
8 LEVOLEUCOVORIN 3 0.0025
9 TEMOZOLOMIDE 33 0.0022
See all drugs enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED